Gruss & Co., LLC
- SEC CIK
- 0001103738
- Latest filing
- Aug 5, 2026
ABCL holding history
AbCellera Biologics Inc. in every 13F filed by Gruss & Co., LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABCL overviewAll 13F holders of ABCLFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −100,000−100.0% | Sold out | Holders |
| Q2 2023 | 100,000 | $646.0K | 3.9% | −67,500−40.3% | Reduced | Holders |
| Q1 2023 | 167,500 | $1.26M | 8.0% | −87,900−34.4% | Reduced | Holders |
| Q4 2022 | 255,400 | $2.59M | 16.0% | −53,170−17.2% | Reduced | Holders |
| Q3 2022 | 308,570 | $3.05M | 26.3% | −55,208−15.2% | Reduced | Holders |
| Q2 2022 | 363,778 | $3.87M | 27.0% | +77,778+27.2% | Added | Holders |
| Q1 2022 | 286,000 | $2.79M | 12.4% | −140,966−33.0% | Reduced | Holders |
| Q4 2021 | 426,966 | $6.11M | 16.4% | −3,441−0.8% | Reduced | Holders |
| Q3 2021 | 430,407 | $8.63M | 24.1% | +430,407 | New | Holders |